Filing Details
- Accession Number:
- 0001127602-13-013857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-12 17:41:42
- Reporting Period:
- 2013-04-12
- Filing Date:
- 2013-04-12
- Accepted Time:
- 2013-04-12 17:41:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1235595 | L Kathryn Biberstein | 852 Winter St. Waltham MA 02451 | Svp, Gc, Secretary, Alks, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-04-12 | 25,000 | $14.57 | 67,665 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-04-12 | 25,000 | $24.61 | 42,665 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2013-04-12 | 25,000 | $0.00 | 25,000 | $14.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-10-17 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.57 to $24.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.